Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery

Kenneth Blum,1– 6 Mark S Gold,7 Nicole Jafari,8,9 Kai-Uwe Lewandrowski,3,5 Alireza Sharafshah,10 Kavya Mohankumar,6 Morgan P Lorio,11 Abdalla Bowirrat,2 Albert Pinhasov,2 Kyriaki Z Thanos,12 Igor Elman,2,13 David Baron,1,14 Catherine A Dennen,15 Brian Fuehrlein,16 Alexander PL Lewandrowski,17 Edward J Modestino,18 Panayotis K Thanos,2,12 Foojan Zeine19,20 1Center for Exercise and Sport Mental Health, Western University Health Sciences, Pomona, CA, USA; 2Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel; 3Center for Advanced Spine Care of Southern Arizona, Tucson, AZ, USA; 4Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; 5Graduate Program, Department of General and Specialized Surgery, Gaffrée E Guinle Universitary Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil; 6Division of Clinical Neurology, The Kenneth Blum Institute of Neurogenetics and Behavior, LLC, Austin, Tx., USA; 7Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; 8Department of Applied Clinical Psychology, The Chicago School of Professional Psychology, Los Angeles, CA., USA; 9Division of Personalized Medicine, Cross-Cultural Research and Educational Institute, San Clemente, CA., USA; 10Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran; 11Advanced Orthopedics, Altamonte Springs, FL., USA; 12Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY., USA; 13Department of psychiatry, Harvard University, School of Medicine, Cambridge, MA., USA; 14Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA., USA; 15Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA., USA; 16Department of Psychiatry, Yale University, New Haven, CT., USA; 17Department of Biological Sciences, Dornsife College of Letters, Arts & Sciences, University of Southern California, Los Angeles, CA., USA; 18Brain & Behavior Laboratory, Department of Psychology, Curry College, Milton, MA., USA; 19Department of Health Science, California State University, Long Beach, CA., USA; 20International Awareness Integration Institute, San Clemente, CA, USACorrespondence: Foojan Zeine, Email [email protected]: Addiction continues to be heavily stigmatized due to lingering misconceptions that frame substance use as a moral failing rather than a treatable neurobiological disorder. This stigma, when internalized, intensifies shame and obstructs recovery. Awareness Integration Theory, a multidisciplinary therapeutic model, addresses these internalized beliefs by identifying and integrating fragmented aspects of the self across thoughts, emotions, behaviors, and promotes self-awareness, emotional regulation, and cognitive restructuring, critical components in reducing shame and fostering resilience. This paper explores the interplay between self-perception, shame, resilience, and biological predisposition in addiction recovery. Research shows that shame-prone individuals are more likely to relapse, while guilt-prone individuals demonstrate greater capacity for change. Resilience, cultivated through self-forgiveness, social support, and neuroplastic interventions, mitigates the impact of shame. Genetic variants and epigenetic modifications influence reward deficiency syndrome, increasing vulnerability to addiction. The Genetic Addiction Risk Severity test can identify at-risk individuals, enabling precision-targeted interventions. Awareness Integration Therapy’s integrative framework complements genomic and neurobiological insights by fostering self-acceptance, enhancing insight into unconscious belief systems, and motivating purposeful action. Neuroimaging studies support the role of resilience-based practices, including those embedded in Alcoholics Anonymous, in promoting dopamine homeostasis and neural recovery. In conclusion, stigma reduction must advance alongside personalized medicine. Integrating Awareness Integration Therapy with genetic screening, trauma-informed care, and psychoeducation offers a comprehensive, compassionate approach. Reframing addiction as a brain-based, treatable condition empowers clients and families, facilitating sustainable recovery grounded in science and self-awareness.Keywords: awareness integration theory, AIT, GARS, genetic addiction risk severity, stigma, shame, addiction, substance abuse

Authors

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2026-02-01
Primary Topic
Neuroethics, Human Enhancement, Biomedical Innovations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery

Modestino EJ, Gold MS, Thanos PK, Fuehrlein B et al.
SHILAP Revista de lepidopterología
Neuroethics, Human Enhancement, Biomedical Innovations
article

Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery

Modestino EJ, Gold MS, Thanos PK, Fuehrlein B, Lorio MP, Jafari N, Sharafshah A, Lewandrowski AP, Mohankumar K, Thanos KZ, Baron D, Zeine F, Blum K, Elman I, Pinhasov A, Lewandrowski KU, Dennen CA, Bowirrat A
article en

Abstract

Kenneth Blum,1– 6 Mark S Gold,7 Nicole Jafari,8,9 Kai-Uwe Lewandrowski,3,5 Alireza Sharafshah,10 Kavya Mohankumar,6 Morgan P Lorio,11 Abdalla Bowirrat,2 Albert Pinhasov,2 Kyriaki Z Thanos,12 Igor Elman,2,13 David Baron,1,14 Catherine A Dennen,15 Brian Fuehrlein,16 Alexander PL Lewandrowski,17 Edward J Modestino,18 Panayotis K Thanos,2,12 Foojan Zeine19,20 1Center for Exercise and Sport Mental Health, Western University Health Sciences, Pomona, CA, USA; 2Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel; 3Center for Advanced Spine Care of Southern Arizona, Tucson, AZ, USA; 4Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; 5Graduate Program, Department of General and Specialized Surgery, Gaffrée E Guinle Universitary Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil; 6Division of Clinical Neurology, The Kenneth Blum Institute of Neurogenetics and Behavior, LLC, Austin, Tx., USA; 7Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; 8Department of Applied Clinical Psychology, The Chicago School of Professional Psychology, Los Angeles, CA., USA; 9Division of Personalized Medicine, Cross-Cultural Research and Educational Institute, San Clemente, CA., USA; 10Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran; 11Advanced Orthopedics, Altamonte Springs, FL., USA; 12Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY., USA; 13Department of psychiatry, Harvard University, School of Medicine, Cambridge, MA., USA; 14Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA., USA; 15Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA., USA; 16Department of Psychiatry, Yale University, New Haven, CT., USA; 17Department of Biological Sciences, Dornsife College of Letters, Arts & Sciences, University of Southern California, Los Angeles, CA., USA; 18Brain & Behavior Laboratory, Department of Psychology, Curry College, Milton, MA., USA; 19Department of Health Science, California State University, Long Beach, CA., USA; 20International Awareness Integration Institute, San Clemente, CA, USACorrespondence: Foojan Zeine, Email [email protected]: Addiction continues to be heavily stigmatized due to lingering misconceptions that frame substance use as a moral failing rather than a treatable neurobiological disorder. This stigma, when internalized, intensifies shame and obstructs recovery. Awareness Integration Theory, a multidisciplinary therapeutic model, addresses these internalized beliefs by identifying and integrating fragmented aspects of the self across thoughts, emotions, behaviors, and promotes self-awareness, emotional regulation, and cognitive restructuring, critical components in reducing shame and fostering resilience. This paper explores the interplay between self-perception, shame, resilience, and biological predisposition in addiction recovery. Research shows that shame-prone individuals are more likely to relapse, while guilt-prone individuals demonstrate greater capacity for change. Resilience, cultivated through self-forgiveness, social support, and neuroplastic interventions, mitigates the impact of shame. Genetic variants and epigenetic modifications influence reward deficiency syndrome, increasing vulnerability to addiction. The Genetic Addiction Risk Severity test can identify at-risk individuals, enabling precision-targeted interventions. Awareness Integration Therapy’s integrative framework complements genomic and neurobiological insights by fostering self-acceptance, enhancing insight into unconscious belief systems, and motivating purposeful action. Neuroimaging studies support the role of resilience-based practices, including those embedded in Alcoholics Anonymous, in promoting dopamine homeostasis and neural recovery. In conclusion, stigma reduction must advance alongside personalized medicine. Integrating Awareness Integration Therapy with genetic screening, trauma-informed care, and psychoeducation offers a comprehensive, compassionate approach. Reframing addiction as a brain-based, treatable condition empowers clients and families, facilitating sustainable recovery grounded in science and self-awareness.Keywords: awareness integration theory, AIT, GARS, genetic addiction risk severity, stigma, shame, addiction, substance abuse

SHILAP Revista de lepidopterología
Allen Institute for Brain Science (US), Adelson Foundation (US), Wisconsin Academy of Sciences, Arts & Letters (US), Matrix Institute on Addictions (US), Desert Institute For Spine Care (US), Department of Medical Sciences (BY), Institute of Behavioral Sciences (JP), Institute of Molecular Medicine (IN), Cellular Research (United States) (US), School of Clinical Research (US)
Good health and well-being
Openalex Percentile: Top 59%
Neuroethics, Human Enhancement, Biomedical Innovations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.